Freeport-McMoRan stock tumbles after Trump imposes copper tariffs
Investing.com - CONMED reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
CONMED announced earnings per share of $0.77 on revenue of $275.09. Analysts polled by Investing.com EPS of $0.75 on revenue of $280.89M.
CONMED 's are up 102.69% and is trading at $80.00 , still down 47.59% from its 52 week high of $159.11 set on Friday, November 5, 2021.
CONMED shares lost 4.07% to trade at $80.00 in after-hours trade the report.
CONMED follows other major Healthcare sector earnings this month
CONMED's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar